Abstract
Cascade testing (CT) for hereditary cancer predisposition syndromes in families of pathogenic variant (PV) carrier enables precisely targeted surveillance and risk-reducing strategies. Genetic test results communication within families is key to enhance CT. The frequency and factors associated with carriers’ disclosure of test results to family members and CT were studied at 2 cancer centers in Mexico.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have